Max Bronstein: The path to progress in public policy is often long, winding, and at times, completely unpredictable

FDA granted accelerated approval to ponatinib with chemotherapy for adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

The FDA Commissioner’s blog on AI – FDA

Samer Al Hadidi: How to counsel patients about Cilta Cel

Blood Cancer Expert Dr. Mikkael Sekeres Endorses FDA Approval of New Drug, Imetelstat

Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine

Lisa A. Lacasse: Hopeful that President Biden calls on Congress to increase funding for cancer research and pass critical legislation that benefits cancer patients and their loved ones

Vincent Rajkumar: Summary of drug approvals in relapsed myeloma

Vincent Rajkumar: How many years of life gained because of FDA accelerated approval in myeloma?

Robert Francomano: Significant change in regulatory priorities by the FDA